Navigation Links
China Sky One Medical Receives GMP Re-Certification
Date:5/27/2010

HARBIN, China, May 27 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that its Tian Long Pharmaceutical Company ("Tian Long") subsidiary successfully obtained renewal of its Good Manufacturing Practices Certificate for Pharmaceutical Products ("GMP Certificate") from the State Food and Drug Administration (SFDA) in China. The new certificate will be valid until May 2015.

According to the National Medicine Administration Law of the PRC, all pharmaceutical manufacturers are required to renew their GMP Certificates every five years. SFDA's examination committee visited Tian Long in April to review its supply chain management practices, including quality control system test, inspect its GMP management process, production records for its five production lines, quality test record and laboratory management.

"Given the extensive scope of the inspection and examination, we are very proud to pass the examination in just one round and successfully renewed the GMP Certificate for Tian Long," said Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical. "China Sky One Medical has built a solid track record of adhering to the highest quality control standards, thanks to our talented and dedicated executives and professional teams in the quality control and production departments."


'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dehaier Medical Systems Continues Product Line Expansion. Signs Exclusive Distribution Agreement with HEYER Medical for Respiratory Products in China
2. China BCT Reports First Quarter 2010 Results
3. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
4. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
5. China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results
6. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 63rd PHARMACHINA Fair
7. China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit
8. China Sky One Medical Provides Sales Forecast for 13 New Products
9. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
10. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
11. China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Israel , July 25, 2014  Galmed Pharmaceuticals ... biopharmaceutical company focused on the development and commercialization of ... diseases and cholesterol gallstones, today announced financial results for ... Half 2014 Financial Summary: , Reported cash and ... compared with $137,000 at December 31, 2013.  , ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today ... a presentation to investors on Tuesday, July 29, ...  The presentation will include an overview of Asterias, ... the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least ...
(Date:7/24/2014)... Quantum computers have yet to materialise. Yet, scientists ... making such computers faster. One such approach relies ... controlled by applying an electric field. A new ... coherently coupled quantum dots (TQDs) with electrical impulses ... for example, should TQDs be used as quantum ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... Inc. (Nasdaq: IDEV ) announced today the ... entitled "Once Daily Dosage Forms,of Trospium," which is ... Supernus Pharmaceuticals, Inc., The ,978 patent covers ... of trospium chloride which is indicated for the,treatment ...
... BRUNSWICK, N.J., Aug. 13 At the upcoming ... R&D Team,Leader, will present "Silicone Elastomer Gels: New ... place in Philadelphia, September 16-17., According to ... molecular,structures that provide differentiated performance features for wound ...
... - Test Cleared to Screen Donated Blood for Hepatitis ... C, on Fully and Semi-Automated Instrument Systems -, ... ) announced today that the US Food and Drug ... the,PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 2Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM) 3Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4
(Date:7/24/2014)... electric cars ply silent freeways, solar panels blanket rooftops ... earth, from howling winds and from the blazing desert ... is technically and economically feasible to convert California,s all-purpose ... Published in Energy , the plan shows the ... in California that could create tens of thousands of ...
(Date:7/24/2014)... has its own microbial terroir, meaning the microbial populations ... in the product, creating the final flavor according to ... Applied and Environmental Microbiology . This is the first ... sake brewery. , Many sake makers inoculate with ... Mills of the University of California, Davis, but he ...
(Date:7/24/2014)... low vision specialist at The University of Texas Health ... awarded a grant to help Harris County residents whose ... surgery. , Even with corrective lenses, many people with ... are a variety of low vision devices, such as ... vision loss. , Iyer is using the three-year, $164,645 ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4The microbes make the sake brewery 2UTHealth Dr. Bhavani Iyer awarded low vision grant 2
... Vascular and Interventional Radiology ,s impact factorthe measure of ... of article citations compared to the total number of ... journal,s quality and influence has remained consistently high over ... been enhanced recently by the increased use of new ...
... A University of Colorado School of Medicine scientist is ... could boost cognitive function in those with Down syndrome, ... potential milestone in research on this genetic condition. ... those with Down syndrome," said Alberto Costa, MD, PhD, ...
... with over half with a depth greater than 3000 ... know that the deep ocean contains a diversity of ... biological and mineral resources. Human activities are, however increasingly ... loss and, with this, the loss of many goods ...
Cached Biology News:Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 2Journal of Vascular and Interventional Radiology increases impact, offers new initiatives 3Researcher tests promising drug on those with Down syndrome 2Man and the last great wilderness: Human impact on the deep sea 2Man and the last great wilderness: Human impact on the deep sea 3Man and the last great wilderness: Human impact on the deep sea 4
Lipid Phosphate Phosphohydrolase 2...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
ANTI-HUMAN CYTOKINES, GROWTH FACTORS (polyclonal rabbit (or goat) antibodies) Human TARC - Biotin...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Biology Products: